NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘pharmaceutical’

1 February 2016

Charterhouse cranks up process for potential Doc Generici sale

tablets-1001224_1920 London-headquartered private equity firm Charterhouse has reportedly contacted investment banks to run a sale of Italian drugmaker Doc Generici, which could see the company valued at up to €700m. Reports from Reuters at the start of December suggested the firm had brought in LEK Consulting to advise on options for the pharmaceutical company, which it[...]

14 December 2015

Carlyle, Hellman & Friedman-backed PPD could hit $8bn valuation through sale, IPO process

drug-1086712_1920 US buyout houses Carlyle and Hellman & Friedman are said to be prepping for a sale or IPO of research business Pharmaceutical Product Development which could value it at up to $8bn.

7 October 2015

European buyout majors eye €700m bidding for French pharma company Cooper

health-846863_1280 European private equity majors including Bridgepoint, BC Partners and Charterhouse Capital are reportedly among firm who could bid about €700m for French pharmaceutical company Cooper.

25 August 2015

Bain Capital backs sterile compound pharma manufacturer QuVa

pills-530372_1280 Bain Capital has bought a majority stake in new sterile compounding pharmacy services platform QuVa Pharma.

22 June 2015

CVC, Temasek take stake in Pamplona-backed pharma company Alvogen

pills-384846_1280 A consortium including CVC Capital Partners and Singapore sovereign investor Temasek is set to buy a controlling stake in Pamplona-backed pharmaceutical company Alvogen.

16 June 2015

Sequoia backs Indian pharma business La Renon with $15.5m

aspirin-156974-m Sequoia Capital has invested INR1bn ($15.5m) in Indian pharmaceutical research, marketing and manufacturing business La Renon Healthcare.

10 June 2015

Fulcrum Venture India hits INR1bn final close for second healthcare, pharma fund

rupees-533387-m Early-stage investor Fulcrum Venture India has beaten its target for its latest healthcare and pharmaceutical fund by closing the vehicle on INR1bn ($15.6m).

1 May 2015

VC-backed Blueprint Medicines floats raising $147m

news_blueprint_lrg Third Rock Ventures-backed enzyme specialist Blueprint Medicines Corp has launched its IPO on the New York Stock Exchange raising $147m.

9 April 2015

Venture capital-backed protein biologics company aTyr Pharma files for IPO

download (4) Rare disease specialist aTyr Pharma, whose venture capital backers include Alta Partners, Cardinal Partners and Domain Associates, has filed for an IPO.

16 March 2015

TPG-backed Par Pharmaceutical registers for IPO

clinic health drugs pharma Generic drugmaker Par Pharmaceutical Holdings, which is owned by TPG has filed for an initial public offering and stated its nominal target as $100m.

Page 1 of 2112345...1020...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2016